Algert Global’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-183,108
| Closed | -$557K | – | 1366 |
|
|
2024
Q4 | $557K | Buy |
183,108
+56,378
| +44% | +$171K | 0.01% | 887 |
|
|
2024
Q3 | $658K | Buy |
126,730
+116,730
| +1,167% | +$606K | 0.02% | 846 |
|
|
2024
Q2 | $26K | Sell |
10,000
-127,260
| -93% | -$331K | ﹤0.01% | 1472 |
|
|
2024
Q1 | $675K | Sell |
137,260
-6,780
| -5% | -$33.3K | 0.03% | 711 |
|
|
2023
Q4 | $1.27M | Buy |
+144,040
| New | +$1.27M | 0.05% | 559 |
|